BioMarin Pharmaceutical
BMRN
#1437
Rank
HK$95.33 B
Marketcap
HK$500.21
Share price
1.28%
Change (1 day)
-27.27%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): HK$6.11

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$6.06. In 2022 the company made an earnings per share (EPS) of HK$5.98 an increase over its 2021 EPS that were of -HK$2.72.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$6.112.04%
2022HK$5.98-319.62%
2021-HK$2.72-107.38%
2020HK$36.90-3485.71%
2019-HK$1.09-67.44%
2018-HK$3.35-34.85%
2017-HK$5.14-83.21%
2016-HK$30.59263.89%
2015-HK$8.4118.68%
2014-HK$7.08-28.91%
2013-HK$9.9634.74%
2012-HK$7.3993.88%
2011-HK$3.81-124.5%
2010HK$15.57
2009N/A-100%
2008HK$2.49-300%
2007-HK$1.25-54.29%
2006-HK$2.72-67.89%
2005-HK$8.48-62.54%
2004-HK$22.65136.59%
2003-HK$9.57-15.17%
2002-HK$11.29-11.59%
2001-HK$12.7756.19%
2000-HK$8.1710.53%
1999-HK$7.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$79.71-1,415.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$11.21-284.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$21.95-462.16%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$24.76 308.43%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$4.98-182.19%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$8.56 41.27%๐Ÿ‡บ๐Ÿ‡ธ USA